semaglutide pancreatitis class action in louisiana Novo Nordisk is suing Eli Lilly over its GLP-1 ads, accusing the rival drugmaker of false advertising for claiming Lilly's Mounjaro and Zepbound outperform Novo's Ozempic and Wegovy. MORE BELOW ⬇️ glp-1 pancreatitis lawsuit in louisiana

"Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline." Journal of Clinical Oncology 36(25): 2647-2655

It's the strongest precedent for dose-splitting in peptide therapy

However, abstracts are typically available for free and can provide a summary of the studys findings

They matter to cost in an indirect but real way: a product taken inconsistently is money spent without the benefit the label describes

In particular, tell your provider if you have a past history of: Type 1 or type 2 diabetes Thyroid cancer Pancreatitis Kidney disease Diabetic retinopathy Depression Suicidal thoughts or behavior Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding